Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
Liver International : Official Journal of the International Association for the Study of the Liver|January 4, 2012
Telaprevir user's guideAnn Marie Liapakis, Ira JacobsonSeminars in Liver Disease|December 23, 2011
The conundrum of relapse in STAT-C therapy: does HCV play the Red Queen or Rip Van Winkle?Robert Ralston, Ira Jacobson, Margaret ScullLiver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 16, 2020
Hepatitis E Virus Infection in the United States: Current Understanding of the Prevalence and Significance in the Liver Transplant Patient Population and Proposed Diagnostic and Treatment StrategiesMaureen Whitsett, David M Feldman, Ira JacobsonAntiviral Therapy|March 10, 2012
Resistance to mericitabine, a nucleoside analogue inhibitor of HCV RNA-dependent RNA polymeraseJean-Michel Pawlotsky, Isabel Najera, Ira JacobsonCurrent Gastroenterology Reports|February 5, 2002
The HCV and HIV coinfected patient: what have we learned about pathophysiology?Andrew H Talal, P Wilfredo Canchis, Ira JacobsonGut|April 17, 2012
New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectivesChristoph Welsch, Arun Jesudian, Stefan Zeuzem, et al.Antiviral Therapy|November 20, 2018
Expert opinion on managing chronic HCV infection in patients with type 2 diabetes mellitusLuigi Elio Adinolfi, Ira Jacobson, Mark Bondin, et al.Current Opinion in Pharmacology|October 7, 2008
Recent progress in the development of selected hepatitis C virus NS3.4A protease and NS5B polymerase inhibitorsAnn D Kwong, Lindsay McNair, Ira Jacobson, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 19, 2009
Efficacy of chronic hepatitis C therapy in community-based trialsPaul Marotta, Dietrich Hueppe, Elmar Zehnter, et al.Pageof 6